Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act.
Saved in:
| Title: | Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act. |
|---|---|
| Authors: | Doernberg H; Yale School of Medicine, New Haven, Connecticut., Wallach JD; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia., Jeffery MM; Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota.; Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota., Mooghali M; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut., Ramachandran R; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut., Ross JS; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.; Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Connecticut. |
| Source: | JAMA internal medicine [JAMA Intern Med] 2026 Feb 01; Vol. 186 (2), pp. 233-242. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41359349 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Doernberg+H%22">Doernberg H</searchLink>; Yale School of Medicine, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Wallach+JD%22">Wallach JD</searchLink>; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Jeffery+MM%22">Jeffery MM</searchLink>; Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota.; Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Mooghali+M%22">Mooghali M</searchLink>; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Ramachandran+R%22">Ramachandran R</searchLink>; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Ross+JS%22">Ross JS</searchLink>; Section of General Medicine and the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.; Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Connecticut. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589534%22">JAMA internal medicine</searchLink> [JAMA Intern Med] 2026 Feb 01; Vol. 186 (2), pp. 233-242. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589534 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6114 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686106%22">21686106 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Intern Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41359349 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamainternmed.2025.6566 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 233 Titles: – TitleFull: Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Doernberg H – PersonEntity: Name: NameFull: Wallach JD – PersonEntity: Name: NameFull: Jeffery MM – PersonEntity: Name: NameFull: Mooghali M – PersonEntity: Name: NameFull: Ramachandran R – PersonEntity: Name: NameFull: Ross JS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2168-6114 Numbering: – Type: volume Value: 186 – Type: issue Value: 2 Titles: – TitleFull: JAMA internal medicine Type: main |
| ResultId | 1 |
